Table 3.

Multivariate analysis of clinical parameters and TILs for cervical cancer survival after NAC

	PFS			OS
	HR	95% CI	P	HR	95% CI	P
OR(OR vs. Non-OR)	0.299	0.039–2.298	0.246	0.412	0.065–3.216	0.967
Clinical response (Yes vs. No)	0.514	0.236–1.120	0.094	0.556	0.204–1.513	0.250
FIGO stage (Ib2 vs. IIa)	1.560	0.686–3.551	0.289	2.212	0.808–6.508	0.122
Intratumoral CD8/Peritumoral FOXP3 after NACT	0.297	0.109–0.810	0.018	0.078	0.010–0.598	0.014